Yearly zoledronic acid at lower-than-standard doses increases bone density, study finds
Monday, June 6, 2011 - 14:30
in Health & Medicine
A lower dose of zoledronic acid than currently recommended for prevention of bone fractures due to osteoporosis decreases bone resorption and increases bone density, and may be effective in reducing the risk of osteoporotic fractures, a study finds.